Acute kidney injury: prevention, detection and management

Evidence

We found 105 studies in a search for randomised controlled trials and systematic reviews published between 1 January 2013 and 12 October 2016. We also considered 4 additional studies identified by members of the guideline committee who originally worked on this guideline.

From all sources, we considered 109 studies to be relevant to the guideline.

We also checked for relevant ongoing research, which will be evaluated again at the next surveillance review of the guideline.

See appendix A: summary of evidence from surveillance for details of all evidence considered, and references.

Views of topic experts

We considered the views of topic experts, including those who helped to develop the guideline and other correspondence we have received since the publication of the guideline.

Views of stakeholders

Stakeholders are consulted only if we decide not to update the guideline following checks at 4 and 8 years after publication.

Stakeholders commented on the decision not to update the guideline. Overall, 9 stakeholders commented. See appendix B for stakeholders' comments and our responses.

Nine stakeholders commented on the proposal to not update the guideline: 4 agreed with the decision; 3 disagreed with the decision; and 2 noted that they had no comments on the proposals. The stakeholders who did not agree with the proposal suggested the areas of diet and lifestyle, patient experience and biomarkers should be updated, however no evidence was identified during the surveillance review or during stakeholder consultation which has an impact on current guideline recommendations. One stakeholder did not provide details as to why they did not agree with the proposal not to update. Several comments suggested extensions to the scope. However, evidence in some of the areas suggested by stakeholders was not sufficient at this time to impact the current guideline. Other areas identified by stakeholders may be more appropriate to be included in the new guideline on perioperative care. Six stakeholders commented on the proposal to remove the research recommendation: 4 agreed with the decision; 2 disagreed with the decision, based on stakeholder feedback the research recommendation will be retained.

See ensuring that published guidelines are current and accurate in developing NICE guidelines: the manual for more details on our consultation processes.

NICE Surveillance programme project team

Sarah Willett and Kay Nolan
Associate Directors

Philip Alderson
Consultant Clinical Adviser

Katrina Sparrow and Judith Thornton
Technical Advisers

Francesca Fasesin
Technical Analyst

The NICE project team would like to thank the topic experts who participated in the surveillance process.

ISBN: 978-1-4731-2446-2